LSTA

Lisata Therapeutics, Inc. NASDAQ Listed Mar 1, 1999

Healthcare ·Biotechnology ·US · lisata.com

$3.23

Mkt Cap $29.4M

52w Low $1.81 43.6% of range 52w High $5.07

50d MA $4.33 200d MA $3.07

P/E (TTM) -1.6x

EV/EBITDA -0.0x

P/B 1.9x

Debt/Equity 0.0x

ROE -111.7%

P/FCF -1.0x

RSI (14) —

ATR (14) —

Beta 1.11

50d MA $4.33

200d MA $3.07

Avg Volume 86.6K

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

SIC Code

2834

CIK (SEC)

320017

Phone

908 842 0100

110 Allen Road · Basking Ridge, NJ 07920 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 12, 2026	AMC	-0.51	-0.33	+35.3%	5.03	-0.4%	+0.0%	+0.2%	+0.0%	-0.4%	-0.2%	—
Nov 6, 2025	AMC	-0.54	-0.49	+9.3%	2.35	-9.4%	-12.3%	-10.6%	-10.6%	-8.1%	-11.9%	—
Aug 7, 2025	AMC	-0.65	-0.54	+16.9%	2.80	-5.0%	-7.1%	-1.1%	-6.4%	-5.0%	-8.6%	—
May 8, 2025	AMC	-0.53	-0.55	-3.8%	2.37	+0.8%	-11.4%	-6.3%	-3.8%	-8.0%	+1.3%	—
Feb 27, 2025	AMC	-0.76	-0.55	+27.6%	2.40	-3.8%	-0.8%	-10.4%	-10.4%	-1.2%	-2.5%	—
Nov 12, 2024	AMC	-0.75	-0.59	+21.3%	2.91	-1.4%	-4.1%	-3.4%	-2.1%	-6.5%	-5.5%	—
Aug 12, 2024	AMC	-0.75	-0.61	+18.7%	2.93	+2.4%	+0.3%	-0.7%	-1.4%	-2.7%	+1.0%	—
May 9, 2024	AMC	-0.73	-0.65	+11.0%	2.91	-0.3%	+1.4%	-4.5%	+1.7%	-2.4%	-3.1%	—
Feb 29, 2024	AMC	-0.86	-0.66	+23.3%	2.93	+0.3%	+5.8%	+10.6%	+6.5%	+5.5%	+4.4%	—
Nov 2, 2023	AMC	-0.93	-0.65	+30.1%	2.18	+2.2%	+8.3%	+4.6%	+2.8%	+2.8%	-3.2%	—
Aug 14, 2023	AMC	-0.70	-0.50	+28.6%	2.70	+0.0%	+0.0%	-0.7%	+0.2%	+0.4%	+0.8%	—
May 9, 2023	AMC	-0.81	-0.77	+4.9%	3.27	-4.9%	-0.5%	+0.2%	+0.9%	+3.7%	+3.1%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 21	Brookline Capital	Downgrade	Buy → Hold	—	$2.16	$3.99	+84.7%	+86.6%	+88.0%	+90.3%	+88.4%	+111.6%
Aug 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.40	$2.38	-0.8%	+2.9%	+7.9%	+5.4%	+4.6%	+4.2%
Jul 15	Brookline Capital	Maintains	Buy → Buy	—	$2.63	$2.53	-3.8%	+2.7%	-2.3%	-8.4%	-3.8%	-1.9%
Dec 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.82	$2.79	-1.1%	-7.1%	-3.2%	-8.5%	-7.4%	-6.0%
Nov 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.93	$2.92	-0.3%	-3.1%	-1.7%	-1.7%	-3.1%	-3.8%
Sep 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.10	$3.05	-1.6%	-4.8%	-2.6%	+2.6%	+0.0%	-4.2%
Aug 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.93	$3.00	+2.4%	+0.3%	-0.7%	-1.4%	-2.7%	+1.0%
Jul 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.55	$3.63	+2.3%	+0.0%	-0.3%	-1.4%	-3.7%	-3.4%
Jul 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.36	$3.41	+1.5%	+1.5%	+3.6%	+9.5%	+8.6%	+10.1%
Jun 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.47	$3.51	+1.2%	+3.7%	-0.9%	-4.9%	-2.9%	+1.7%
May 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.82	$2.86	+1.4%	+6.4%	+10.3%	+12.4%	+5.0%	+2.1%
Apr 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.66	$2.74	+3.0%	-0.4%	+3.4%	+2.6%	+7.1%	+10.2%
Apr 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.83	$2.75	-2.8%	-6.0%	-6.4%	-2.8%	-3.5%	+0.7%
Mar 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.93	$2.94	+0.3%	+5.8%	+10.6%	+6.5%	+5.5%	+4.4%
Jan 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.80	$3.05	+8.9%	+7.9%	+5.4%	+9.6%	+10.0%	+7.1%
Aug 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.70	$2.70	+0.0%	+0.0%	-0.7%	+0.2%	+0.4%	+0.8%
May 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.11	$4.08	-0.7%	-5.1%	-5.6%	-6.1%	-0.2%	+3.4%
Mar 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.18	$3.02	-5.0%	+2.0%	+2.2%	+0.0%	-3.0%	-3.1%
Oct 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.18	$4.41	+5.5%	-1.2%	-0.5%	-1.2%	-4.8%	-4.3%

Data updated apr 25, 2026 7:58pm · Source: massive.com